To learn more about this report, Request sample copy
The North America dominates the global peripheral vascular devices market and is projected to hold 44.8% of the market share in 2024. The region has a highly developed healthcare infrastructure and presence of major industry players. Many leading device manufacturers such as Medtronic, Boston Scientific, and Abbott Vascular are headquartered in the U.S. These companies invest heavily in R&D to develop innovative products which strengthens the country's device portfolio. Furthermore, reimbursement policies in the U.S. are favorable for new device adoption. The presence of both private and public payers provides ample funding sources for peripheral procedures. Device pricing is also relatively higher compared to other regions due to the high usage and demand. This enhances revenue generation for companies from the North America market.
Asia Pacific is emerging as one of the fastest growing markets for peripheral vascular devices. There is significant growth potential owing to China’s large patient population and increasing disease burden of peripheral artery disease. The Chinese government is focusing on modernizing its healthcare system and improving access through initiatives such as Healthy China 2030. This will increase the affordability of advanced devices. Additionally, many global companies are actively engaged in expanding their manufacturing and distribution footprint in China to cater to the rising demand. Local device manufacturers are also strengthening their R&D and production capabilities. The growing foreign direct investments in the sector signal strong interest from multinational players to tap into China’s market opportunities. While import duties remain high for certain product categories, trade volumes are progressively increasing.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients